Abstract
An important step in understanding receptor function is determining the tissues and cells in which they are expressed. Classical physiological, biochemical, and membrane binding studies, however, usually provide inadequate spatial resolution to determine the anatomical and cellular localisation of specific receptors, particularly where there is a multiplicity of receptor subtypes. Therefore, alternative methods have been developed to provide the required anatomical and cellular resolution, the most widely used of which is in vitro receptor autoradiography. The methods are relatively simple and versatile and are applicable to the analysis of secondary messenger systems, ion channels, and enzymes (see Chapter 11) as well as receptors and may be used in combination with complementary techniques such as immunohistochemistry and in situ hybridization (1). The widespread use of receptor autoradiography reflects the utility of the technique and the advantages it offers over membrane binding studies, in particular the capacity both to localize and quantify ligand binding within heterogeneous tissues without compromising either ligand binding or histological preservation. It is possible to detect and analyze regional differences in the distribution of receptor subtypes within a single tissue sample and thereby derive information that would be difficult, if not impossible, to obtain with other methods.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Wharton, J., Walsh, D. A., Rutherford, R. A. D., Knock, G. A., and Polak, J. M. (1993). In vitro autoradiographic localisation and characterization of binding sites, in Receptor Autoradiography: Principles and Practice (Wharton, J. and Polak, J. M., eds.) Oxford University Press, Oxford, pp. 79–105.
Wilkins, M. R., Nunez, D. J., and Wharton, J. (1993) The natriuretic peptide family: turning hormones into drugs. J. Endocrinol. 137, 347–359.
Anand-Srivastava, M. B. and Trachte, J. E. (1993) Atrial natriuretic factor receptors and signal transduction mechanisms. Pharmacol. Rev. 45, 455–497.
De Léan, A., Thibault, G., Seidah, N. G., Lazure, C., Gutkowska, J., Chrétien, M., Genest, J., and Cantin, M. (1985) Structure-activity relationships of atrial natriuretic factor (ANF) III. Correlation of receptor affinity with relative potency on aldosterone production in zona glomerulosa cells. Biochem. Biophys. Res. Commun. 132, 360–367.
Chinkers, M. Garbers, D. L., Chang, M., Lowe, D. G., Chin, H., Goeddel, D. V., and Schulz, S. (1989) A membrane form of guanylate cyclase is an atrial natriuretic peptide receptor. Nature (London). 338, 78–83.
Bennett, B. D., Bennett, G. L., Vitangcol, R. V., Jewett, J. R., Burnier, J., Henzel, W., and Lowe, D. G. (1991) Extracellular domain IgG fusion proteins for three human natriuretic peptide receptors. Hormone pharmacology and application to solid phase screening of synthetic peptide antisera. J. Biol. Chem. 266, 23,060–23,067.
Suga, S., Nakao, K., Hosoda, K., Mukoyama, M., Ogawa, Y., Shirakami, G., Arai, H., Saito, Y., Kambayashi, Y., Inouye, K., and Imura, H. (1992) Receptor selectivity of natriuretic peptide family, atrial natriuretic peptide, brain natriuretic peptide, and C-type natriuretic peptide. Endocrinol. 130, 229–239.
Porter, J. G., Arfsten, A., Fuller, F., Miller, J. A., Gregory, L. C., and Lewicki, J. A. (1990) Isolation and functional expression of the human atrial natriuretic peptide clearance receptor cDNA. Biochem. Biophys. Res. Commun. 171, 796–803.
Maack, T., Suzuki, M., Almeida, F. A., Nussenzveig, D., Scarborough, R. M., McEnroe, G. A., and Lewicki, J. A. (1987) Physiological role of silent receptors of atrial natriuretic factor. Science. 238, 675–678.
Prins, B. A., Weber, M. J., Hu, R. M., Pedram, A., Daniels, M., and Levin, E. R. (1996) Atrial natriuretic peptide inhibits mitogen-activated protein kinase through the clearance receptor. Potential role in the inhibition of astrocyte proliferation. J. Biol. Chem. 271, 14,156–14,162.
Anand-Srivastava, M. B., Sehl, P. D., and Lowe, D. G. (1996) Cytoplasmic domain of natriuretic peptide receptor-C inhibits adenylyl cyclase. Involvement of a pertussis toxin-senstive G protein. J. Biol. Chem. 271, 19,324–19,329.
Scarborough, R. M., McEnroe, G. A., Arfsten, A., Kang, L-L., Schwartz, K., and Lewicki, J. A. (1988) D-amino acid-substituted atrial natriuretic peptide analogs reveal novel receptor recognition requirements. J. Biol. Chem. 263, 16,818–16,822.
Brown, J., Salas, A. A., Singleton, A., Polak, J. M., and Dollery, C. T. (1990) Autoradiographic localization of atrial natriuretic peptide receptor subtypes in rat kidney. Am. J. Physiol. 259, F26–F39.
Rutherford, R. A. D., Wharton, J., Needleman, P., and Polak, J. M. (1991) Autoradiographic discrimination of brain and atrial natriuretic peptide binding sites in rat kidney. J. Biol. Chem. 266, 5819–5826.
Rutherford, R. A. D., Wharton, J., Gordon, L., Moscoso, G., Yacoub, M. H., and Polak, J. M. (1992) Endocardial localization of natriuretic peptide binding sites in human fetal and adult heart. Eur. J. Pharmacol. 212, 1–7.
Rutherford, R. A. D., Matsuda, Y, Wilkins, M. R., Polak, J. M., and Wharton, J. (1994) Identification of renal natriuretic peptide receptor subpopulations by use of the nonpeptide antagonist, HS-142-1. Br. J. Pharmacol. 113, 931–939.
Brown, L. A., Rutherford, R. A. D., Nunez, D. J. R., Wharton, J., Lowe, D. G., and Wilkins, M. R. (1997) Downregulation of natriuretic peptide C-receptor protein in the hypertrophied ventricle of the aortovenocaval fistula rat. Cardiovasc. Res. 36, 363–371.
Mimeault, M., Fournier, A., Féthiere, J., and De Léan, A. (1993) Development of natriuretic peptide analogs selective for the atrial natriuretic factor-R1A receptor subtype. Mol. Pharmacol. 43, 775–782.
Morishita, Y., Sano, T., Kase, H., Yamada, K., Inagami, T., and Matsuda, Y. (1992) HS-142-1, a novel nonpeptide atrial natriuretic peptide (ANP) antagonist, blocks ANP-induced renal responses through a specific interaction with guanylyl cyclase-linked receptors. Eur. J. Pharmacol. 225, 203–207.
Tanaka, T., Ichimura, M., Nakajo, S., Snajdar, R. M., Morishita, Y., Sano, T., Yamada, K., Inagami, T., and Matsuda, Y. (1992) HS-142-1, a novel non-peptide antagonist for atrial natriuretic peptide receptor, selectively inhibits particulate guanylyl cyclase and lowers cyclic GMP in LLC-PK1 cells. Biosci. Biotech. Biochem. 56, 1041–1045.
Timmermans, P. B. M. W. M., Wong, P. C., Chiu, A. T., Herblin, W. F., Benfield, P., Carini, D. J., Lee, R. J., Wexler, R. R., Saye, J. A. M. E., and Smith, T. D. (1993) Angiotensin II receptors and angiotensin II receptor antagonists. Pharmacol. Rev. 45, 205–251.
Whitebread, S., Mele, M., Kamber, B., and DeGasparo, M. (1989) Preliminary biochemical characterization of two angiotensin II receptor subtypes. Biochem. Biophys. Res. Comm. 163, 284–291.
Chiu, A. T., McCall, D. E., Price, W. A., Wong, P. C., Carini, D. J., Duncia, J. V., Johnson, A. L., Wexler, R. R., Yoo, S. E., and Timmermans, P. B. M. W. M. (1990) Nonpeptide angiotensin II receptor antagonists. VII. Cellular and biochemical pharmacology of DuP 753, an orally active antihypertensive agent. J Pharmacol. Exp. Ther. 252, 711–718.
Weinstock, J, Keeman, R. M., Samanen, J., Hempel, J., Finkelstein, J. A., Franz, R. G., Gaitanpooulos, D. E., Girard, G. R., Gleason, J. G., Hill, D. T., Morgan, T. M., Peisoff, C. E., Aiyar, N., Brooks, T. M., Fredrickson, T. A., Ohlstein, E. H., Ruffolo, R. R., Stack, E. J., Sulpizio, A. C., Weidley, E. F., and Edwards, R. M. (1991) 1-(Carboxybenzyl)-imidazole-5-arcylic acids: Potent and selective angiotensin II receptor antagonists. J Med. Chem. 34, 1514–1517.
Dudley, D. T., Panek, R. L., Major, T. C., Lu, G. H., Bruns, R. F., Klinkefus, B. A., Hodges, J. C., and Weishaar, R. E. (1990) Subclasses of angiotensin II binding sites and their functional significance. Mol. Pharmacol. 38, 370–377.
Whitebread, S., Taylor, V., Bottari, S. P., Kamber, B., and DeGasparo, M. (1991) Radio-iodinated CGP 42112A: a novel high affinity and highly selective ligand for the characterization of angiotensin AT2 receptors. Biochem. Biophys. Res. Commun. 181, 1365–1371.
Speth, R. C. and Kim, K. H. (1990) Discrimination of two angiotensin II receptor subtypes with a selective agonist analogue of angiotensin II, p-aminophenylalanine6 angiotensin II. Biochem. Biophys. Res. Commun. 169, 997–1006.
Chiu, A. T., McCall, D. E., Nguyen, T. T., Carini, D. J., Duncia, J. V., Herblin, W. F., Uyeda, T., Wong, P. C., Wexler, R. R., Johnson, A. L., and Timmermans, P. B. M. W. M. (1989) Discrimination of angiotensin II receptor subtypes by dithiothreitol. Eur. J Pharmacol. 170, 117–118.
Sechi, L. A., Grady, E. F., Griffin, C. A., Kalinyak, J. E., and Schamblelan, M. (1992) Distribution of angiotensin receptor subtypes in rat and human kidney. Am. J. Physiol. 262, F236–F240.
Gröne, H-J., Simon, M., and Fuchs, E. (1992) Autoradiographic characterization of angiotensin receptor subtypes in fetal and adult human kidney. Am. J. Physiol. 262, F326–F331.
Walsh, D. A., Suzuki, T., Knock, G. A., Blake, D. R., Polak, J. M., and Wharton, J. (1994) AT1 receptor characteristics of angiotensin analogue binding in human synovium. Br. J. Pharmacol. 112, 435–442.
Knock, G. A., Sullivan, M. H. F., McCarthy, A., Elder, M. G., Polak, J. M, and Wharton, J. (1994) Angiotensin II (AT1) vascular binding sites in human placentae from normal-term, preeclamptic and growth retarded pregnancies. J. Pharmacol. Exp. Ther. 271, 1007–1015.
Lefroy, D. C., Wharton, J., Knock, G. A., Suzuki, T., Crake, T., Morgan, K., Polak, J. M., and Poole-Wilson, P. A. (1996) Regional changes in angiotensin II receptor density after experimental myocardial infarction. J. Mol. Cell. Cardiol. 28, 429–440.
Walsh, D. A., Hu, D. E., Wharton, J., Catravas, J. D., Blake, D. R., and Fan T. P. F. (1997) Sequential development of angiotensin receptors and angiotensin I converting enzyme during angiogenesis in the rat subcutaneous sponge granuloma. Br. J. Pharmacol. 120, 1302–1311.
Brilla, C. G., Zhou, G., Matsubara, L., and Weber, K. T. (1994) Collagen metabolism in cultured rat cardiac fibroblasts: response to angiotensin II and aldosterone. J. Mol. Cell. Cardiol. 26, 809–820.
Lokuta, A. J., Cooper, C., Gaa, S. T., Wang, H. E., and Rogers, T. B. (1994) Angiotesin II stimulates the release of phospholipid-derived second messengers through multiple receptor subtypes in heart cells. J. Biol. Chem. 269, 4832–4838.
Stoll, M., Steckelings, M., Paul, M., Bottari, S. P., Metzger, R., and Unger, T. (1995) The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells. J. Clin. Invest. 95, 651–657.
Nakajima, M., Hutchinson, H. G., Fujinaga, M., Hayashida, W., Morishita, R., Zhang, L., Horiuchi, M., Pratt, R. E., and Dzau, V. J. (1995) The angiotensin II type 2 (AT2) receptor antagonizes the growth effects of the AT1 receptor: gain-of-function study using gene transfer. Proc. Natl. Acad. Sci. USA 92, 10,663–10,667.
Levy, B. I., Benessiano, J., Henrion, D., Caputa, L., Heymes, C., Duriez, M., Poitevlin, P., and Samuel, L. (1996) Chronic blockade of AT2-subtype receptors prevents the effect of angiotensin II on rat vascular structure. J. Clin. Invest. 98, 418–425.
Booz, G. W. and Baker, K. M. (1996) Role of type 1 and type 2 angiotensin receptors in angiotensin II-induced cardiomyocyte hypertrophy. Hypertension 28, 635–640.
Brink, M., Erne, P., De Gasparo, M., Rogg, H., Schmid A., Stulz, P., and Bullock, G. (1996) Localization of the angiotensin II receptor sutypes in the human atrium. J. Mol. Cell. Cardiol. 28, 1789–1799.
Grady, E. F., Sechi, L. A., Griffin, C. A., Schamblelan, M., and Kalinyak, J. E. (1991) Expression of AT2 receptors in the developing rat fetus. J. Clin. Invest. 88, 921–933.
Viswanathan, M., Tsutsumi, K., Correa, F. M. A., and Saavedra, J. M. (1991) Changes in expression of angiotensin receptor subtypes in the rat aorta during development. Biochem. Biophys. Res. Commun. 179, 1361–1367.
Nozawa, Y., Haruno, A., Oda, N., Yamasaki, Y., Matsuura, M., Yamada, S., Inabe, K., Kimura, R., Suzuki, H., and Hoshino, T. (1994) Angiotensin II receptor subtypes in bovine and human ventricular myocardium. J. Pharmacol. Exp. Ther. 270, 566–571.
Regitz-Zagrosek, V., Friedel, N., Heymann, A., Bauer, P., Neu, M., Rolfs, A., Steffen, C., Hildebrandt, A., Hetzer, R., and Fleck, E. (1995) Regulation, chamber localization, and subtype distribution of angiotensin II receptors in human hearts. Circulation 91, 1461–1471.
Rogg, H., De Gasparo, M., Graedel, E., Stulz, P., Burkart, F., Eberhard, M., and Erne, P. (1996) Angiotensin II-receptor subtypes in the human atria and evidence for alterations in patients with cardiac dysfunction. Eur. Heart J. 17, 1112–1120.
Nishimura, H., Walker, O., Patton, C., Madison, A., Chiu, A., and Keiser, J. (1994) Novel angiotensin receptor subtypes in fowl. Am. J. Physiol. 267, R1174–1181.
Walsh, D. A., Wharton, J., Blake, D. R., and Polak, J. M. (1993) Species and tissue specificity of vasoactive regulatory peptides. Int. J. Tissue Cell. Reactions 15, 109–124.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Humana Press Inc., Totowa, NJ
About this protocol
Cite this protocol
Wharton, J., Walsh, D.A. (1999). Autoradiography of Peptide Receptors. In: Keen, M. (eds) Receptor Binding Techniques. Methods in Molecular Biology, vol 106. Springer, Totowa, NJ. https://doi.org/10.1385/0-89603-530-1:99
Download citation
DOI: https://doi.org/10.1385/0-89603-530-1:99
Publisher Name: Springer, Totowa, NJ
Print ISBN: 978-0-89603-530-0
Online ISBN: 978-1-59259-579-2
eBook Packages: Springer Protocols